Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40
NCT07055425 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-09-05
Summary
This study will look at how well a measure called the Qmax/eGFR ratio is related to the severity of urination problems in men over the age of 40. Qmax is a test that shows how fast a person can urinate, and eGFR is a number that reflects kidney function. Men who have urinary symptoms will be asked to do a urine flow test, a blood test, and fill out a questionnaire about their symptoms and quality of life. We will study if there is a link between the Qmax/eGFR ratio and how severe their symptoms are. The results may help doctors better understand how kidney and urinary function are related in men with these problems.
Conditions
- Lower Urinary Tract Symptom
- Voiding Dysfunction
- Male Urological Health
- Renal Function
- Benign Prostate Obstruction (BPO)
Sponsors & Collaborators
-
Marmara University
lead OTHER
Eligibility
- Min Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2026-01-01
- Completion
- 2026-05-01
More Related Trials
-
The Association of Baseline Characteristics of Male Patients Presented With LUTS and Long Term Clinical Outcomes
NCT04764903 ·Status: COMPLETED
-
Association of Urine BDNF and NGF With Lower Urinary System Parameters
NCT06265519 ·Status: RECRUITING ·Phase: NA
-
A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy
NCT00700505 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
NCT05530655 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
NCT05834270 ·Status: COMPLETED ·Phase: NA
-
Identification and Treatment of Men With BPH in the Primary Care Setting
NCT00211640 ·Status: COMPLETED
-
Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1
NCT01661621 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
NCT05508165 ·Status: RECRUITING ·Phase: NA
-
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
NCT01736033 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients
NCT02244229 ·Status: COMPLETED ·Phase: PHASE4
-
The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic Hyperplasia:A Single-center Paired Validating Confirmatory Study
NCT06448533 ·Status: COMPLETED
-
Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy
NCT06865430 ·Status: RECRUITING ·Phase: NA
-
Intermittent vs Daily Tamsulosin for LUTS/BPH
NCT07308002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)
NCT01250483 ·Status: COMPLETED
-
HoLEP: Learning Curve Analysis and Comparison With TURP
NCT06849089 ·Status: COMPLETED
-
BE Technologies Mobile Uroflowmetry Validation Study
NCT04599283 ·Status: COMPLETED ·Phase: NA
-
Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH
NCT04987892 ·Status: RECRUITING ·Phase: PHASE4
-
Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men with BPH
NCT05686525 ·Status: RECRUITING ·Phase: NA
-
Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH
NCT03179670 ·Status: COMPLETED
-
Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH
NCT05023824 ·Status: UNKNOWN ·Phase: PHASE3
-
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
NCT01457573 ·Status: COMPLETED ·Phase: PHASE4
-
Early Versus Late Catheter Removal in Patients With Acute Urinary Retention Secondary to BPH Under Tamsulosin Treatment
NCT03280420 ·Status: COMPLETED ·Phase: NA
-
The Use of REZUM System in Chinese Male Patients With LUTS Secondary to Benign Prostate Enlargement
NCT04340934 ·Status: TERMINATED ·Phase: NA
-
Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT06051383 ·Status: COMPLETED ·Phase: NA
-
Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
NCT03669692 ·Status: WITHDRAWN ·Phase: NA